New guidance for targeting residual ovarian tumors

Researchers who are working on an implantable device that could make intraperitoneal chemotherapy more bearable have published a new study that offers insight into how to improve chemotherapy strategies for ovarian cancer, and how to determine which patients would be most likely to benefit from their device. (Mehr in: Cancer News — ScienceDaily)